Endo International PLC (ENDP)

ENDP (NASDAQ:Drugs) EQUITY
$13.29
pos +0.14
+1.06%
Today's Range: 12.95 - 13.59 | ENDP Avg Daily Volume: 6,152,400
Last Update: 02/27/17 - 4:00 PM EST
Volume: 9,085,927
YTD Performance: -18.70%
Open: $13.12
Previous Close: $13.15
52 Week Range: $12.56 - $88.54
Oustanding Shares: 222,876,797
Market Cap: 2,984,320,312
6-Month Chart
TheStreet Ratings Grade for ENDP
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 9 8
Moderate Buy 1 1 1 1
Hold 10 10 9 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.17 2.17 2.00 2.06
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 1.47
Price Earnings Comparisons:
ENDP Sector Avg. S&P 500
1.47 0.00 30.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-19.82% -73.82% -82.93%
GROWTH 12 Mo 3 Yr CAGR
Revenue 13.60 0.10 0.03
Net Income 0.00 -0.60 0.00
EPS 0.00 0.20 0.00
Earnings for ENDP:
EBITDA 1.01B
Revenue 3.27B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $1.63 $1.41 $4.58 $4.24
Number of Analysts 11 6 12 12
High Estimate $1.73 $1.69 $4.69 $4.71
Low Estimate $1.55 $1.15 $4.51 $3.95
Prior Year $1.36 $1.08 $4.87 $4.58
Growth Rate (Year over Year) 19.72% 30.56% -5.94% -7.37%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
We answer recent reader questions about three of the biotech stocks we regularly cover.
Not much action in the markets since our last update with the major indices continuing to grind slightly higher as we try to close out a solid…
Even among the losers, buys are scarce.
If you use TVIX and VXX put in an above-market limit order, or if you trade options buy calls on the VIX.
In our last post we discussed large-cap biotech names that have been beaten up in 2016, are cheap and hopefully will see better days in 2017. Here are a few small-cap biotechs I would keep an eye on in 2017.
Which stocks have shown these patterns in the past week.
Thursday felt a lot like capitulation in this space. I was buying.
It appears Twitter will need more than takeover chatter to stay aloft, Oppenheimer analysts say.
Cutting down the 7 best S&P 500 stocks in August to a field of 2.
These stocks show technical characteristics of changing course.

Columnist Conversations

On Friday NVDA opened with its second straight gap lower open as the steep pullback from the Jan/Feb highs con...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.